康辰药业 (603590)

1. Key Indicators

• Total Shares(W): 15935.65
• Circulating A-Shares(W): 15822.35
• Earnings Per Share(RMB): 0.8100
• Net Assets Per Share(RMB): 20.0616
• Operating Revenue(W RMB): 69222.04
• Total Profit(W RMB): 14821.13
• **Net Profit Attributable to Parent(W RMB) **: 12788.01
• Net Profit Growth Rate(%): 13.19
• Weighted Return on Equity(%): 4.0400
• Operating Cash Flow Per Share(RMB): 0.5270
• Undistributed Profit Per Share(RMB): 12.8101
• Capital Reserve Per Share(RMB): 5.9773

---

2. Main Business

The main business covers:

• Research and development of pharmaceuticals
• Production of pharmaceuticals
• Sales of pharmaceuticals

---

3. Company Basic Information

• Company Name: Beijing Konruns Pharmaceutical Co., Ltd.
• Listing Date: 2018-08-27
• Industry: Pharmaceutical Manufacturing
• Address: No. 11, Xingsheng South Road, Economic Development Zone, Miyun District, Beijing
• Website: https://www.konruns.cn
• Company Profile: The company was established by Liu Jianhua and 11 other shareholders as promoters through the overall transformation of Konruns Limited into a joint stock limited company. On August 16, 2013, Konruns Limited held a board meeting and passed a resolution to approve the overall transformation of Konruns Limited into a joint stock limited company. All the debts and credits of Konruns Limited were to be inherited by the newly transformed joint stock limited company, and all the original shareholders of Konruns Limited were to become the promoters of the joint stock limited company. On August 22, 2013, all the promoters of Konruns Pharmaceutical signed the "Sponsor Agreement." According to the audit report issued by Daxin Certified Public Accountants (Special General Partnership), the total audited net assets of Konruns Limited were RMB 250,291,000. According to the asset appraisal report issued by Zhongjing Minxin (Beijing) Asset Appraisal Co., Ltd., the total appraised net assets of Konruns Limited were RMB 413,285,800. All promoters agreed to convert the net assets of Konruns Limited into 120,000,000 shares held by the promoters in the company, all of which are ordinary shares denominated in RMB, with a par value of RMB 1.00 per share. The remaining portion of the net assets was recorded as the company's capital reserve. The shareholding ratio of the promoters in the company is equivalent to their proportion of registered capital in Konruns Limited, and the shares they subscribed for are all ordinary shares denominated in RMB.

---

4. Top 10 Circulating Shareholders

Rank	Institution Name	Institution Type	Shares Held (W)	Percentage Held (%)
1	Beijing Muren Investment Management Co., Ltd.	General Legal Person	1624.56	10.27
2	Beijing Puhua Jiye Investment Consulting Center (Limited Partnership)	General Legal Person	960.00	6.07
3	Qianhai Kaiyuan Shanghai-Hong Kong-Shenzhen Advantage Selection Flexible Allocation Mixed Securities Investment Fund A Class	Fund	174.45	1.10
4	Qianhai Kaiyuan China Scarce Assets Flexible Allocation Mixed Securities Investment Fund A Class	Fund	160.75	1.02
5	HTF Medical Positive Growth One-Year Holding Mixed Securities Investment Fund A Class	Fund	155.34	0.98
6	HTF Healthcare Mixed Securities Investment Fund	Fund	143.84	0.91
7	Qianhai Kaiyuan National Comparative Advantage Flexible Allocation Mixed Securities Investment Fund A Class	Fund	143.78	0.91
8	Qianhai Kaiyuan Medical Health Flexible Allocation Mixed Securities Investment Fund A Class	Fund	134.03	0.85
9	Bodo Jiaxing One-Year Holding Mixed Securities Investment Fund	Fund	45.77	0.29
10	Fuguo Tiansheng Flexible Allocation Mixed Securities Investment Fund	Fund	41.25	0.26

---

5. Concept Sectors

• Venture Capital Concept
• Intellectual Property
• Generic Drugs
• Innovative Drugs

---

Remarks

• Data update date: 2025-11-03
• Data source: Public Market Information